Ultragenyx Pharmaceutical | RARE - Trade Debtors

Stock Price
24.67
Daily Change
0.88 3.70%
Monthly
1.94%
Yearly
-45.60%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $112.54M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Agios Pharmaceuticals USD 5.03M 43K Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Insmed USD 65.26M 10.23M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Kyowa Hakko Kirin JPY 151.83B 6.88B Sep/2025
MacroGenics USD 69.23M 56.7M Sep/2025
Moderna USD 1.05B 589M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025